BRISTOL MYERS SQUIBB FDA Approval NDA 018731

NDA 018731

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #018731

Documents

Letter2002-02-07
Letter2010-11-30
Label2003-04-14
Label2001-07-19
Label2010-11-22
Letter2001-07-19
Letter2007-09-25
Review2004-04-14
Label2003-04-14
Label2007-09-26
Review2019-02-15

Application Sponsors

NDA 018731BRISTOL MYERS SQUIBB

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004

Application Products

001TABLET;ORAL5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1BUSPARBUSPIRONE HYDROCHLORIDE
002TABLET;ORAL10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1BUSPARBUSPIRONE HYDROCHLORIDE
003TABLET;ORAL15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1BUSPARBUSPIRONE HYDROCHLORIDE
004TABLET;ORAL30MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1BUSPARBUSPIRONE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1986-09-29PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1986-12-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1986-12-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1987-04-23PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1989-07-25PRIORITY
LABELING; LabelingSUPPL8AP1989-07-25PRIORITY
LABELING; LabelingSUPPL9AP1987-08-10PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1988-06-23PRIORITY
LABELING; LabelingSUPPL11AP1988-11-02PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1989-03-02PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1989-03-02PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1988-10-13PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1989-04-28PRIORITY
LABELING; LabelingSUPPL18AP1991-07-31PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1990-01-26PRIORITY
LABELING; LabelingSUPPL20AP1998-03-02PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1990-01-26PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1990-10-05PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1996-04-22PRIORITY
LABELING; LabelingSUPPL26AP1993-09-23PRIORITY
LABELING; LabelingSUPPL27AP1996-04-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL29AP1996-03-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL30AP1996-06-19PRIORITY
EFFICACY; EfficacySUPPL31AP1996-04-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL32AP1996-12-30PRIORITY
LABELING; LabelingSUPPL33AP1998-05-20PRIORITY
LABELING; LabelingSUPPL34AP1998-05-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL35AP1998-04-03PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL36AP1998-06-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL38AP1999-01-27PRIORITY
LABELING; LabelingSUPPL39AP2001-05-03PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL40AP1999-07-27PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL41AP1999-11-01PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL42AP2000-04-25PRIORITY
EFFICACY; EfficacySUPPL43AP2001-07-19PRIORITY
LABELING; LabelingSUPPL45AP2001-05-03PRIORITY
LABELING; LabelingSUPPL46AP2002-02-07PRIORITY
LABELING; LabelingSUPPL48AP2007-09-21PRIORITY
LABELING; LabelingSUPPL51AP2010-11-22PRIORITY

Submissions Property Types

ORIG1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL23Null0
SUPPL25Null0
SUPPL26Null0
SUPPL27Null0
SUPPL29Null0
SUPPL30Null0
SUPPL31Null0
SUPPL32Null0
SUPPL33Null0
SUPPL34Null0
SUPPL35Null0
SUPPL36Null0
SUPPL38Null0
SUPPL39Null0
SUPPL40Null0
SUPPL41Null0
SUPPL42Null0
SUPPL43Null0
SUPPL45Null0
SUPPL46Null0
SUPPL48Null0
SUPPL51Null0

CDER Filings

BRISTOL MYERS SQUIBB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18731
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUSPAR","activeIngredients":"BUSPIRONE HYDROCHLORIDE","strength":"5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"BUSPAR","activeIngredients":"BUSPIRONE HYDROCHLORIDE","strength":"10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"BUSPAR","activeIngredients":"BUSPIRONE HYDROCHLORIDE","strength":"15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"BUSPAR","activeIngredients":"BUSPIRONE HYDROCHLORIDE","strength":"30MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"11\/22\/2010","submission":"SUPPL-51","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/018731s051lbl.pdf\"}]","notes":""},{"actionDate":"09\/21\/2007","submission":"SUPPL-48","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/018731s048lbl.pdf\"}]","notes":""},{"actionDate":"07\/19\/2001","submission":"SUPPL-43","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/18731s43lbl.pdf\"}]","notes":""},{"actionDate":"05\/03\/2001","submission":"SUPPL-45","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/18731s39s45lbl.pdf\"}]","notes":""},{"actionDate":"05\/03\/2001","submission":"SUPPL-39","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/18731s39s45lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"BUSPAR","submission":"BUSPIRONE HYDROCHLORIDE","actionType":"5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"BUSPAR","submission":"BUSPIRONE HYDROCHLORIDE","actionType":"10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"BUSPAR","submission":"BUSPIRONE HYDROCHLORIDE","actionType":"15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"BUSPAR","submission":"BUSPIRONE HYDROCHLORIDE","actionType":"30MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2010-11-22
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.